These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 13476667)

  • 1. Sensitivity of Mycobacterium tuberculosis to para-aminosalicylic acid, isoniazid, and the P.A.S. salt of isoniazid.
    DUNBAR JM; RITCHIE RT
    Lancet; 1957 Sep; 273(6996):612-3. PubMed ID: 13476667
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the drug resistance in Mycobacterium tuberculosis var. hominis.
    MIURA K; NODA Y; TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):182-5. PubMed ID: 13385195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance of Mycobacterium tuberculosis to antituberculotics in synthetic culture media].
    BANYASZ T
    Tuberkulozis; 1957; 10(5-6):107-9. PubMed ID: 13496268
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance determination in practice in a tuberculosis clinic].
    ERMISCH K; ERMISCH U
    Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 8. [New laboratory accomplishments in thoracic pathology].
    CETRANGOLO A
    Rev Med Cubana; 1956 May; 67(5):418-25. PubMed ID: 13371028
    [No Abstract]   [Full Text] [Related]  

  • 9. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity to antituberculous drugs of bacillary strains from initial tuberculosis in children].
    DEBRE R; FOUSSEREAU S; NOUFFLARD H
    Presse Med (1893); 1956 Oct; 64(78):1791-3. PubMed ID: 13389308
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of 58 titrations of sensitivity to streptomycin, PAS and isoniazid of Mycobacterium tuberculosis].
    BURDIN JC; SCHMITT J; de LAVERGNE ; BRIQUEL P; RIBAR D
    Rev Med Nancy; 1960 Feb; 85():131-5. PubMed ID: 13806020
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.
    DUNBAR FP; DAVIS R; JEFFERIES MB
    Am Rev Tuberc; 1958 Feb; 77(2):350-5. PubMed ID: 13509034
    [No Abstract]   [Full Text] [Related]  

  • 13. The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis.
    SINGH B; MITCHISON DA
    J Gen Microbiol; 1955 Aug; 13(1):176-84. PubMed ID: 13252227
    [No Abstract]   [Full Text] [Related]  

  • 14. A quantitative analysis of the resistance of Mycobacterium tuberculosis to streptomycin, isoniazid and PAS.
    TSUKAMURA M; NODA Y; MIURA K
    Kekkaku; 1956 Feb; 31(2):107-10. PubMed ID: 13320628
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on double or triple resistance of Mycobacterium tuberculosis. 1. The rate of appearance of double or triple resistance, and the effect of drugs on the appearance of this resistance].
    KUROIWA K
    Kekkaku; 1960 Jul; 35():492-8. PubMed ID: 13755309
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental experiments on combined effects of three anti-tuberculous agents, streptomycin, PAS and isoniazid. I. Studies mainly on the course of the resistance development of M. tuberculosis serially transferred in the cultural environment of three drugs used concomitantly].
    MIYAMOTO Y; UENO K
    Kekkaku; 1955 Nov; 30(11):659-63. PubMed ID: 13286850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Result of sensitivity evaluation of human, bovine and avian tuberculosis bacteria].
    NASSAL J; PETERSEN KF
    Tuberkulosearzt; 1961 Sep; 15():589-97. PubMed ID: 14478466
    [No Abstract]   [Full Text] [Related]  

  • 19. EMERGENCE of bacterial resistance in pulmonary tuberculosis under treatment with isoniazid, streptomycin plus P.A.S. and streptomycin plus isoniazid.
    Lancet; 1953 Aug; 265(6779):217-23. PubMed ID: 13070601
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the biological properties of the laboratory strains of Mycobacterium avium. 3rd Report. Susceptibility to para-aminosalicylic acid, isoniazid and neotetrazolium].
    TAKEYA K; YAMAURA K; IKEGAMI W
    Kekkaku; 1960 Feb; 35():88-91. PubMed ID: 13836688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.